Dishman Carbogen Amcis Ltd

Dishman Carbogen Amicis is engaged in the process of research and development to late-stage clinical and commercial manufacturing.

Pros:
Stock is trading at 0.48 times its book value
Cons:
Company might be capitalizing the interest cost

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
434 362 534 340 444 460 451 482 448 479 650 522
321 263 388 270 311 339 330 361 319 346 480 402
Operating Profit 113 99 146 70 133 121 121 121 129 133 169 119
OPM % 26% 27% 27% 21% 30% 26% 27% 25% 29% 28% 26% 23%
Other Income 13 16 4 7 9 15 16 6 15 13 20 8
Interest 20 13 10 11 13 13 11 15 15 14 13 14
Depreciation 55 51 57 51 55 55 50 54 58 58 71 67
Profit before tax 51 50 83 14 74 68 75 58 71 74 106 46
Tax % 25% 35% 48% 6% 35% 38% 32% 32% 38% 31% 28% 26%
Net Profit 38 32 43 13 48 42 51 40 44 51 76 34
EPS in Rs 3.00 2.60 3.17 2.46 2.73 3.18 4.70 2.13
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 TTM
1,714 1,695 2,059 2,098
1,261 1,249 1,507 1,548
Operating Profit 452 445 552 550
OPM % 26% 26% 27% 26%
Other Income 26 46 54 56
Interest 49 49 57 56
Depreciation 214 211 240 253
Profit before tax 216 231 309 297
Tax % 33% 33% 32%
Net Profit 145 155 210 205
EPS in Rs 9.58 13.03 12.74
Dividend Payout % 0% 0% 2%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:14.20%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:13.42%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:-31.73%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:3.95%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
0 32 32
Reserves 4,814 5,075 5,347
Borrowings 950 1,095 1,042
1,046 1,189 1,140
Total Liabilities 6,810 7,391 7,561
4,852 5,066 5,098
CWIP 133 151 175
Investments 40 196 167
1,785 1,979 2,121
Total Assets 6,810 7,391 7,561

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
303 226 282
-107 -297 -169
-137 78 -102
Net Cash Flow 59 7 11

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
ROCE % 5% 6%
Debtor Days 61 96 79
Inventory Turnover 3.72 3.98